iBrands Corporation Appoints New CEO And Changes Business Focus
07 juin 2021 09h30 HE
|
iBrands Corporation
LAS VEGAS, June 07, 2021 (GLOBE NEWSWIRE) -- iBrands Corporation (OTC: IBRC) (“the Company”), a diversified holdings company, is pleased to announce the appointment of Billionaire Frank Ekejija as...
iBrands Corporation Launches Nano Sport Nutraceutical
10 mai 2021 09h00 HE
|
iBrands Corporation
LAS VEGAS, May 10, 2021 (GLOBE NEWSWIRE) -- (OTC PINK: IBRC) ("the Company"), a diversified holding and branding company, announces that through its subsidiary iBrands Farms, has launched Nano...
iBrands Corporation Becomes Product Sponsor For Professional Football Franchise
03 mai 2021 09h30 HE
|
iBrands Corporation
LAS VEGAS, May 03, 2021 (GLOBE NEWSWIRE) -- iBrands Corporation (OTC PINK: IBRC) ("the Company"), a diversified holding and branding company, announces that through its subsidiary iBrands Farms, has...
iBrands Corporation Provides Update to Shareholders
30 mars 2021 11h41 HE
|
iBrands Corporation
LAS VEGAS, March 30, 2021 (GLOBE NEWSWIRE) -- iBrands Corporation (OTC PINK: IBRC) ("the Company"), a diversified holding and branding company, announces a update to shareholders and interested...
iBrands Corporation Reports Reduction of Brain Inflammation/Depression Associated Biochemical Pathway Using QuadraMune™ in Animal Studies
29 juin 2020 09h00 HE
|
iBrands Corporation
LAS VEGAS, June 29, 2020 (GLOBE NEWSWIRE) -- iBrands Corporation (OTC: IBRC) (“the Company”), a diversified holding and branding company, announces filing of a new patent by nutraceutical product...
iBrands Corporation Reports QuadraMune Reduces Myeloid Suppressor Cells in 4T1 Mouse Model of Breast Cancer
22 juin 2020 09h00 HE
|
iBrands Corporation
LAS VEGAS, June 22, 2020 (GLOBE NEWSWIRE) -- iBrands Corporation (OTC: IBRC) (“the Company”), a diversified holding and branding company, announces novel data suggesting that QuadraMune™...
iBrands Corporation Announces Clinical Trial For Immune Booster Product
17 juin 2020 09h00 HE
|
iBrands Corporation
LAS VEGAS, June 17, 2020 (GLOBE NEWSWIRE) -- iBrands Corporation (OTC: IBRC) (“the Company”), a diversified holding and branding company, announces clinical trial for Quadramune™, the Company’s...
iBrands Corporation Adds Immune Booster To Nutraceutical Product Line
27 avr. 2020 09h10 HE
|
iBrands Corporation
LAS VEGAS, April 27, 2020 (GLOBE NEWSWIRE) -- iBrands Corporation (OTC: IBRC) (“the Company”), a diversified holding and branding company, announces that it has, through its wholly owned subsidiary...
iBrands Corporation Enters Into Distribution Agreement With Medical Supply Group
23 mars 2020 09h00 HE
|
iBrands Corporation
LAS VEGAS, March 23, 2020 (GLOBE NEWSWIRE) -- iBrands Corporation (OTC: IBRC) ("the Company"), a diversified holding and branding company, announces that it has, through its wholly owned subsidiary...
iBrands Corporation Enhances Net Stockholder Equity
12 févr. 2020 09h00 HE
|
iBrands Corporation
LAS VEGAS, Feb. 12, 2020 (GLOBE NEWSWIRE) -- iBrands Corporation (OTC: IBRC) (“the Company”), a diversified holding and branding company, announces that the board has recently amended the company’s...